Clinical Trials Logo

Facial Pain clinical trials

View clinical trials related to Facial Pain.

Filter by:
  • Withdrawn  
  • Page 1

NCT ID: NCT06021561 Withdrawn - Multiple Sclerosis Clinical Trials

Orofacial Pain in Multiple Sclerosis

Start date: September 4, 2023
Phase:
Study type: Observational

Although the orofacial pain is not typical symptom of multiple sclerosis, more than 50% of the patients experience some kind of pain. Acute pain usually in form of trigeminal neuralgia, that occurred in 2-3% of patients with multiple sclerosis. Chronic pain occurred in 40-50% of patients and most common forms are headache. Aim of this study is to investigate prevalence and evaluate the form of orofacial pain in patients with multiple sclerosis treated in General hospital Varaždin in period from 01.01. 2017. to 31.12.2022. Results of this investigation will determine better understanding orofacial pain , treatment and impact on everyday life.

NCT ID: NCT02957097 Withdrawn - Pain, Postoperative Clinical Trials

Gabapentin as a Pre-emptive Analgesic in Oral and Maxillofacial Surgical Procedures

Start date: September 2019
Phase: Phase 4
Study type: Interventional

The purpose of this study is to assess the effectiveness of pre-operative administration of gabapentin 900 mg in management of acute post-operative pain in patients undergoing oral and maxillofacial surgical procedures.

NCT ID: NCT01920087 Withdrawn - Clinical trials for Atypical Facial Pain

Efficacy and Safety of ATNC05 in Treatment of Atypical Facial Pain

AFP
Start date: March 2014
Phase: Phase 2/Phase 3
Study type: Interventional

The purpose of the study is to test the efficacy of ATNC05 in the treatment of Atypical Facial Pain (AFP), also known as Persistent Idiopathic Facial Pain (PIFP). This research project targets patients with chronic constant facial pain and excludes patients with primarily paroxysmal pain.

NCT ID: NCT01327326 Withdrawn - Clinical trials for Temporomandibular Disorder

Role of the Endogenous Opioid System Underlying Modulation of Experimental Pain

Start date: December 2011
Phase: N/A
Study type: Interventional

The aim of this proposal is to characterize pain inhibition in healthy controls and Temporomandibular Disorder (TMD) patients with two models of endogenous pain modulation (off-set analgesia; conditioned pain modulation), and to investigate the function of the endogenous opioid system in these responses by using pharmacological blockade of the opioid receptor.